The Catalyst Pharmaceuticals, Inc., CPRX has Remain Flat (=) on Monday, December 02, 2019 the stock price is settled at $4.64 after buying and selling hours while rehearsed a difference of 0 percent. The stock has a fifty two-week low of $150.81 percent while its fifty two-weeks high are $-39.5 percent.
The total market cap for the stock is $482.28M while it has a PE ratio of 55.9. Active investor focuses on important indicators rehearsed a difference in session that includes where the Catalyst Pharmaceuticals, Inc..
Each buying and selling session display one-of-a-kind actions and patterns about Catalyst Pharmaceuticals, Inc. (CPRX) stock. Presently we watched the different factors that seen on close of last session. Toward the day’s end, it’s only a stock’s exhibition that issues.
Catalyst Pharmaceuticals, Inc.’s overall performance:
The performance of the stock during the last 7.00 days was 4.27 percent,
during the last one-month price index is -1.9 percent while over the 3.00 months is -24.18 percent.
Its 6.00 months performance has been 33.72 percent while for the beyond 52.00 weeks is 67.51 percent.
We have additionally seen that the stock is exchanging -6.83 percent away from the 50-day MA and 0.22 percent of the 20-day MA.
How much shares are traded?
The stock traded hands with 1495807 numbers of shares contrast to its normal every day volume of 2.45M shares.
What amount of stock is unpredictable?
Beta factor was seen at 2.36. Beta estimates the hazard of the security. High beta >1 means implies higher dangerous and low beta <1 shows low peril. The stock remained 5.84 percent erratic for the ongoing week and 6.93 percent for the last month.
Catalyst Pharmaceuticals, Inc. has a P/S and P/B values of 6.63 and 6.11 respectively. Its P/Cash valued at 6.3. The CPRX has PEG of 0. Technical indicators do not lead us to assume the stock will see more gains anytime soon.
Analyst’s mean target amount for the company is 9 while analysts mean suggestion is 0.